reflected fundamental changes taking place in the pharmaceutical industry. GROWTH IN MANAGED CARE Managed care plans typically provide members with medical insurance and basic health care services, using volume and long-term contracts to negotiate discounts from health care providers. In addition, managed care programs provide full coverage for prescription drugs more frequently than do traditional medical insurance plans. Industry experts estimate that by the turn of the century
Words: 4749 - Pages: 19
0 0 0 0 0 0 4 0 0 4 0 0 0 0 0 0 10 MB 13417 Functional Electives Marketing Finance Systems Human Resource Operations Vertical Electives Pharma Hospitality Enterprise Resource Planning Agriculture Hospital and Health Care Retailing Auto Industry Project Management Media and Communication Banking Financial Service Insurance 2 MB 13FM01 MB 13FM02 MB 13FM03 MB 13FM04 MB 13FM05 MB 13FM06 MB 13FM07 MB 13FM08 MB 13FM09 MB 13FM10 MB 13FM11 MB 13FM12 MB 13FM13 MB 13HR01 MB 13HR02 MB
Words: 53231 - Pages: 213
· Executive summary………..………………………………………..3 · Introduction…………………………………………….…………...5 · Section 1- Environment/ Industry analysis….................…………....5 · Section 2- Company Description………….....……………………..7 · Section 3- Financial analysis………………...………………….…..8 · Section 4- Marketing Strategy………………………...……...…...10 · Section 5- Use of Information Technology………..………...…….11 · Section 6- Ethical/ Environmental Issues….....………….………..12 · Conclusion…………………………
Words: 4430 - Pages: 18
portfolio of beauty, fashion and home brands to satisfy women globally. We encourage utilizations of the latest technology with the intent of pursuing new growth opportunities that will bring wealth for all of our stakeholders. We firmly believe in our values of trust, respect, belief, humility and integrity for people and for the environment. D. External Audit EFE Matrix Key External Factors | Weights | Rating | Weighted Score | Opportunities | | | | Focus on
Words: 2067 - Pages: 9
Term Paper Report On Competitive Marketing Policies & Strategies Of Pharmaceutical Products in Bangladesh Submitted to Mr. Abdus Samad Chowdhury Senior Management Councilor Bangladesh Institute of Management Submitted By MD. MAHAFUZUR RAHMAN ID: 14MM028 Post Graduate Diploma In Marketing Management Date of Submission 21-12- 2014. Bangladesh Institute of Management Department of Marketing Management Letter of Transmittal December 21, 2014 Mr. Abdus Samad Chowdhury
Words: 9861 - Pages: 40
Chapter 1 Introduction 1.0 Introduction Financial analysis and performance evaluation of a company are vital facts for any company in today’s world. It includes different aspects of the company. This analysis assesses the viability, stability and profitability of the company. At some level every business decision involves financial analysis and valuation. Outside the firm, security analysts conduct financial analysis and valuation to support their buy/sell decision. This is necessary to price
Words: 10980 - Pages: 44
in Pfizer issuing in excess of 19.9% of its outstanding common stock as a result of the merger Deal Terms Breakdown: Transaction Value Transaction Consideration Purchase price per WYE share $50.19 Existing Cash Used $22,213 32.7% Cash per WYE share $33.00 New Debt $22,500 33.1% PFE stock value per WYE share $17.19 Total Cash $44,713 65.8% PFE shares per WYE share 0.985
Words: 8308 - Pages: 34
Essential Oils and Plant Extracts Five-Year R&D Plan 2008 – 2013 RIRDC Shaping the future Essential Oils and Plant Extracts Five-Year R&D Plan 2008 to 2013 May 2008 RIRDC Publication No 08/053 © 2008 Rural Industries Research and Development Corporation. All rights reserved. ISBN 1 74151 642 0 ISSN 1440-6845 Essential Oils and Plant Extracts R&D Five-Year Plan 2008–2013 Publication No. 08/053 The information contained in this publication is intended for general use to assist
Words: 10572 - Pages: 43
Research and Analysis Project for B.sc (Hons) In Applied Accounting Business and Financial Performance Of GlaxoSmithKline Pakistan Ltd (2007- 2009) XXXXXXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXXXXXX Prepared by Faisal Saleem XXXXXXXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXXXXXXXXXXXXXXXXXXXXX Mentoring by Fahim Ahmed This project is prepared in accordance with Oxford Brookes University guidelines
Words: 12319 - Pages: 50
Value Chain Analysis M. Porter introduced the generic value chain model in 1985. Value chain represents all the internal activities a firm engages in to produce goods and services. VC is formed of primary activities that add value to the final product directly and support activities that add value indirectly. Michael Porter published the Value Chain Analysis in 1985 as a response to criticism that his Five Forces framework lacked an implementation methodology that bridged the gap between internal
Words: 1997 - Pages: 8
